CLAYTON BLANKENSHIP: Open Payments
NPI 1790178440 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,289 in 122 payments from 20 companies in 2025. Trend: 2023 $2,365 · 2024 $3,228 · 2025 $2,289
Food & beverage: $2,289Education: $1
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 38 | $487 |
| ABBVIE INC. | 18 | $364 |
| GlaxoSmithKline, LLC. | 10 | $218 |
| Lilly USA, LLC | 7 | $159 |
| UCB, Inc. | 8 | $138 |
| ANI Pharmaceuticals, Inc. | 6 | $130 |
| Novartis Pharmaceuticals Corporation | 6 | $119 |
| Janssen Biotech, Inc. | 4 | $118 |
| E.R. Squibb & Sons, L.L.C. | 5 | $113 |
| AstraZeneca Pharmaceuticals LP | 3 | $82 |
Products named: SKYRIZI, BENLYSTA, OTEZLA, TALTZ, RINVOQ, Bimzelx, KRYSTEXXA, PURIFIED CORTROPHIN GEL.
Industry payments across CA — which companies pay providers there.
